Vaccines
The Regulatory Affairs Professionals Society releases a daily intelligence briefing, Regulatory Reconnaissance, that provides a comprehensive overview of the latest regulatory news and updates from around the world. The briefing highlights key developments in the pharmaceutical and medical device industries, including new product approvals, clinical trials, and regulatory policies. A
Vaccines
Sen. Elizabeth Warren has spoken out against the huge conflict of interest of COVID-19 vaccine czar Moncef Slaoui, who holds $10 million in stock options in Moderna Inc., one of the companies working on a COVID-19 vaccine. Slaoui was appointed by President Donald Trump to lead the White House'
Vaccines
The US FDA has granted fast-track status to a potential COVID-19 vaccine being developed by Moderna in collaboration with the National Institutes of Health. This vaccine works differently than traditional vaccines, using messenger RNA to instruct the body's immune system to fight the virus. The NIH has moved
Coronaviruses
Cancer Research UK and Lineage Cell Therapeutics have signed a clinical trial and option agreement, allowing Lineage to conduct an early exercise of its option to acquire data from Cancer Research UK's ongoing Phase 1 clinical trial of VAC2 in non-small cell lung cancer (NCT03371485). Lineage will assume
Coronaviruses
Researchers at NYU Langone Health have begun enrolling healthy patients in a clinical trial to test four experimental mRNA vaccine candidates developed by Pfizer and BioNTech. The trial aims to determine whether the vaccines can prevent infection with the virus that causes COVID-19. The trial is being conducted at NYU
Vaccines
British scientists working on the coronavirus vaccine have announced that they will know by early summer whether their experimental jab will be effective. The team, led by Oxford University, has partnered with pharmaceutical giant AstraZeneca to produce millions of doses at cost price, ensuring that the UK will be at
Vaccines
The University of Oxford has announced a significant partnership with pharmaceutical giant AstraZeneca to develop, manufacture, and distribute its Covid-19 vaccine candidate, following human trials that began last week. The agreement aims to enable rapid vaccination around the world if the vaccine proves to be effective. The vaccine is being
Vaccines
Global efforts to combat the COVID-19 pandemic have accelerated with the World Health Organization (WHO) reporting six novel coronavirus vaccines in clinical trials. Oxford University has joined the list of vaccine candidates published by the WHO, alongside Moderna Inc., Inovio Pharmaceuticals Inc., and Chinese companies Sinovac, CanSino Biological Inc., and
Vaccines
New Jersey Senators Cory Booker and Bob Menendez have urged 15 pharmaceutical companies engaged in COVID-19 related work to prioritize diversity in vaccine or trial development, citing the disproportionate impact of the pandemic on communities of color and other minority groups. The senators argue that comprehensive demographic and racial data
Pharmaceutical industry
Researchers from Pfizer Inc. presented data from a randomized, controlled Phase 2 study of its meningococcal serogroup B vaccine, TRUMENBA[R], coadministered with routine meningococcal (groups A, C, Y and W) (MCV4) and tetanus, diphtheria and pertussis (Tdap) vaccines in adolescents. The study involved 2,600 healthy individuals aged 10-12
Influenza viruses
President Obama's Department of Health and Human Services (HHS) has been criticized for approving the distribution of the H1N1 vaccine to Wall Street firms, including Citigroup, Goldman Sachs, and JP Morgan Chase, while the vaccine remains scarce and inaccessible to most Americans. According to a recent report, 13
Influenza viruses
The World Health Organization (WHO) has received a significant donation from Temptime Corporation, which will provide Vaccine Vial Monitors (VVMs) to monitor the potential heat damage of H1N1 vaccines distributed to developing countries. This generous contribution aims to ensure the safe distribution and administration of vaccines during a pandemic situation.
